Visit | MMSE-ADAS-Cog total change scores | MMSE-SIB total change scores | ||||||
Week | N | MMSE | ADAS-Cog | r | N | MMSE | SIB | r |
Week 1 | 149 | 0.69 (2.34) | −0.92 (3.68) | −0.11 | ||||
Week 3 | 594 | 0.76 (2.61) | −2.04 (4.31) | −0.28 | ||||
Week 6 | 991 | 0.74 (2.82) | −1.64 (4.65) | −0.28 | 1225 | 0.52 (2.35) | 2.05 (7.07) | 0.31 |
Week 9 | 560 | 0.98 (3.05) | −1.57 (4.70) | −0.32 | ||||
Week 12 | 957 | 0.76 (3.05) | −1.17 (5.11) | −0.36 | 1156 | 0.76 (2.76) | 2.36 (7.72) | 0.37 |
Week 18 | 380 | 0.06 (3.16) | −0.36 (5.31) | −0.39 | 1095 | 0.71 (2.94) | 2.47 (8.74) | 0.43 |
Week 24 | 379 | −0.31 (3.35) | 0.03 (5.76) | −0.45 | 1548 | 0.53 (3.08) | 1.02 (10.42) | 0.44 |
All r values were statistically significant (p<0.05), except the correlation at week 1 between the MMSE and ADAS-Cog where p=0.18. Spearman’s correlation coefficient values may be interpreted as weak (0.10–0.39), moderate (0.40–0.69) and strong (0.70–0.89).
ADAS-Cog, Alzheimer’s Disease Assessment Scale–Cognitive Subscale; MMSE, Mini-Mental State Examination; N, the sample size that varies owing to different visit schedules across trials; r, Spearman’s correlation coefficient; SIB, Severe Impairment Battery.